These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 9444451

  • 21. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y, Sasamura H, Ikeda S, Ikegami N, Saruta T.
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [Abstract] [Full Text] [Related]

  • 22. [One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients].
    Simonyi G, Ferenci T, Finta E, Medvegy M, Wittmann I.
    Orv Hetil; 2023 Aug 27; 164(34):1337-1341. PubMed ID: 37634155
    [Abstract] [Full Text] [Related]

  • 23. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.
    JAMA; 2004 Dec 15; 292(23):2849-59. PubMed ID: 15598916
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Initial treatment of hypertension and adherence to therapy in general practice in Italy.
    Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Sangiorgi Cellini G, Vaccheri A, De Ponti F, Montanaro N.
    Eur J Clin Pharmacol; 2005 Sep 15; 61(8):603-9. PubMed ID: 16082539
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Sep 15; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun 15; 61(3):218-23. PubMed ID: 22695025
    [Abstract] [Full Text] [Related]

  • 34. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.
    Ishida T, Oh A, Hiroi S, Shimasaki Y, Nishigaki N, Tsuchihashi T.
    Hypertens Res; 2019 Feb 15; 42(2):249-256. PubMed ID: 30443023
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents.
    Small RE, Freeman-Arnold SB, Goode JV, Pyles MA.
    Pharmacotherapy; 1997 Feb 15; 17(5):1011-6. PubMed ID: 9324190
    [Abstract] [Full Text] [Related]

  • 36. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.
    Pharmacoepidemiol Drug Saf; 2001 May 15; 10(3):219-27. PubMed ID: 11501335
    [Abstract] [Full Text] [Related]

  • 37. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    JAMA; 2002 Dec 18; 288(23):2981-97. PubMed ID: 12479763
    [Abstract] [Full Text] [Related]

  • 38. Effectiveness of treatment of newly diagnosed hypertension in family medicine practices in South Croatia.
    Jurić D, Pavličević I, Marušić A, Malički M, Buljan I, Šarotić V, Mrduljaš-Đujić N, Komparak A, Vujević M, De Micheli-Vitturi D, Šušnjar P, Puljiz T, Jerčić M, Leskur D, Marušić M.
    BMC Fam Pract; 2019 Jan 14; 20(1):10. PubMed ID: 30642264
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.
    Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, Guan J, Lam K, Luke MJ, Read SH, Stall NM, Wu W, Zhu L, Rochon PA, McCarthy LM.
    JAMA Intern Med; 2020 May 01; 180(5):643-651. PubMed ID: 32091538
    [Abstract] [Full Text] [Related]

  • 40. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun 01; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.